세계의 기업 이미징 IT 시장 예측(-2030년) : 기능별, 모달리티별, 용도별, 치료별, 최종사용자별, 지역별

The global enterprise imaging IT market is projected to reach USD 4.12 billion by 2030 from USD 2.31 billion in 2025, at a CAGR of 12.2% during the forecast period. Demand is propelled by the shift from capital-heavy license models to cloud native SaaS deployments, which lower upfront costs and accelerate upgrades.

The emergence of blockchain-backed image provenance platforms is enhancing data integrity and auditability across multi-vendor ecosystems. Growing medical tourism networks are driving the need for standardized, cross-border image exchange hubs, while the proliferation of point-of-care ultrasound and wearable imaging devices is expanding enterprise workflows to include real-time, bedside acquisitions.

"The diagnostics segment is the fastest-growing segment in the enterprise imaging IT market within the forecast period."

Based on applications, the enterprise imaging IT market has been divided into diagnostics, therapeutics, and clinical research. The diagnostics segment accounts for the largest share of the enterprise imaging IT market. This segment's large share and high growth can be attributed to the nationwide rollout of lung cancer screening programs, which has surged low-dose CT volumes and driven enterprise archive demand. The integration of AI-driven triage engines that automatically flag critical findings such as intracranial hemorrhages or pulmonary emboli has also pushed providers to upgrade diagnostic platforms. Additionally, the rise of quantitative radiomics and texture analysis workflows for oncology and neurology imaging is creating demand for solutions that can store, process, and mine high-dimensional feature sets at scale.

"The cardiology segment is estimated to hold the largest share of the enterprise imaging IT market in 2024, by therapeutic area."

Based on therapeutic area, the enterprise imaging IT market is segmented into neurology, cardiology, oncology, orthopedics, and other therapeutic areas. The cardiology segment held the largest share in 2024 due to the surge in CT-derived fractional flow reserve (FFR CT) workflows, which require seamless integration of computational models and high-fidelity CT archives. The rapid expansion of hybrid cath lab/OR suites is driving the demand for enterprise viewers that can overlay 3D vessel reconstructions in real time during transcatheter valve and structural interventions. New CPT codes for AI-quantified ejection fraction and chamber volumetrics are also incentivizing hospitals to deploy platforms with built-in cardiac analytics. Additionally, the proliferation of wearable ECG and implantable device data streams is pushing cardiology departments to adopt enterprise solutions that fuse multi source signals with imaging studies for comprehensive cardiac risk stratification.

"The Asia Pacific region is expected to register the highest growth rate in the enterprise imaging IT market during the forecast period."

The global enterprise imaging IT market is segmented into five major regions: North America, Europe, Asia Pacific, Latin America, and the Middle East & Africa. In 2024, Asia Pacific is expected to register the highest growth for enterprise imaging IT in the forecast period. Factors such as India's National Digital Health Mission integrating imaging data into its Health Locker for unified patient records, the rise of medical tourism hubs in Malaysia and Thailand demanding seamless cross border image exchange, public-private partnerships deploying mobile CT and MRI units in rural China, and the explosive uptake of low cost, AI powered handheld ultrasound devices in South Korea and India are all fueling Asia Pacific's rapid enterprise imaging IT adoption.

The breakdown of primary participants is as mentioned below:

• By Company Type: Tier 1 (41%), Tier 2 (31%), and Tier 3 (28%)
• By Designation: C-level Executives (44%), Directors (31%), and Others (25%)
• By Region: North America (45%), Europe (28%), Asia Pacific (20%), Latin America (4%), and the Middle East & Africa (3%)

Key Players

The prominent players in this market are Agfa-Gevaert Group (Belgium), FUJIFILM Corporation (Japan), Merative (US), Pro Medicus, Ltd. (Australia), Optum, Inc. (US), GE HealthCare (US), Intelerad (Canada), Sectra AB (Sweden), CANON MEDICAL SYSTEMS CORPORATION (Japan), Hyland Software, Inc. (US), Koninklijke Philips N.V. (Netherlands), Siemens Healthineers AG (Germany), INFINITT Healthcare Co., Ltd. (South Korea), Novarad (US), Mach7 Technologies (US), Hermes Medical Solutions (Sweden), Konica Minolta, Inc. (Japan), BridgeHead Software Ltd. (England), Sclmage, Inc. (US), VISUS Health IT GmbH (Germany), Dicom Systems, Inc. (US), PostDICOM (Netherlands), Qaelum (Belgium), AdvaHealth Solutions (Singapore), PaxeraHealth (US), and Rad AI (US). Players adopted organic and inorganic growth strategies such as solution launches, enhancements, and upgrades; collaborations; partnerships; acquisitions; agreements; and expansions to increase their offerings, cater to customers' unmet needs, increase their profitability, and expand their presence in the global market.

Research Coverage

• The report studies the enterprise imaging IT market based on function, modality, application, offering, deployment mode, therapeutic area, end user, and region.
• The report analyzes factors (such as drivers, restraints, opportunities, and challenges) affecting the market growth.
• The report evaluates the opportunities and challenges in the market for stakeholders and provides details of the competitive landscape for market leaders.
• The report studies micromarkets with respect to their growth trends, prospects, and contributions to the total enterprise imaging IT market.
• The report forecasts the revenue of market segments with respect to five major regions.

Reasons to Buy the Report

The report can help established firms, as well as new entrants/smaller firms, gauge the pulse of the market, which, in turn, would help them garner a greater share. Firms purchasing the report could use one or a combination of the five strategies mentioned below.

This report provides insights into the following pointers:

• Analysis of key drivers, restraints, opportunities, and challenges influencing the growth of the enterprise imaging IT market.
• Product Development/Innovation: Detailed insights on upcoming technologies, research and development activities, and product launches in the enterprise imaging IT market.
• Market Development: Comprehensive information about lucrative emerging markets. The report analyzes the markets for various types of enterprise imaging IT solutions across regions.
• Market Diversification: Exhaustive information about products, untapped regions, recent developments, and investments in the enterprise imaging IT market.
• Competitive Assessment: In-depth assessment of market shares, strategies, products, distribution networks, and manufacturing capabilities of the leading players in the enterprise imaging IT market.

TABLE OF CONTENTS

1 INTRODUCTION

• 1.1 STUDY OBJECTIVES
• 1.2 MARKET DEFINITION
• 1.3 MARKET SCOPE
  • 1.3.1 MARKET SEGMENTATION & REGIONAL SCOPE
  • 1.3.2 INCLUSIONS & EXCLUSIONS
• 1.4 YEARS CONSIDERED
• 1.5 CURRENCY
• 1.6 LIMITATIONS
• 1.7 STAKEHOLDERS

2 RESEARCH METHODOLOGY

• 2.1 RESEARCH DATA
  • 2.1.1 SECONDARY DATA
    • 2.1.1.1 Key data from secondary sources
  • 2.1.2 PRIMARY DATA
    • 2.1.2.1 Key data from primary sources
    • 2.1.2.2 Breakdown of primary sources
• 2.2 RESEARCH APPROACH
• 2.3 MARKET SIZE ESTIMATION
• 2.4 MARKET BREAKDOWN & DATA TRIANGULATION
• 2.5 RESEARCH ASSUMPTIONS
  • 2.5.1 MARKET SIZING ASSUMPTIONS
  • 2.5.2 OVERALL STUDY ASSUMPTIONS
• 2.6 RISK ASSESSMENT
• 2.7 RESEARCH LIMITATIONS
  • 2.7.1 METHODOLOGY-RELATED LIMITATIONS
  • 2.7.2 SCOPE-RELATED LIMITATIONS

3 EXECUTIVE SUMMARY

4 PREMIUM INSIGHTS

• 4.1 ENTERPRISE IMAGING IT MARKET OVERVIEW
• 4.2 NORTH AMERICA: ENTERPRISE IMAGING IT MARKET, BY APPLICATION & REGION
• 4.3 ENTERPRISE IMAGING IT MARKET: GEOGRAPHIC SNAPSHOT
• 4.4 ENTERPRISE IMAGING IT MARKET: DEVELOPED VS. EMERGING ECONOMIES

5 MARKET OVERVIEW

• 5.1 INTRODUCTION
• 5.2 MARKET DYNAMICS
  • 5.2.1 DRIVERS
    • 5.2.1.1 Increased demand for scalable and cost-effective solutions
    • 5.2.1.2 Advancements in AI and imaging technologies
    • 5.2.1.3 Growing volume of medical imaging procedures
    • 5.2.1.4 Growing need for remote access and collaborative care
    • 5.2.1.5 Government initiatives and favorable policies
  • 5.2.2 RESTRAINTS
    • 5.2.2.1 Data security and privacy concerns
    • 5.2.2.2 Lack of skilled professionals for deployment and interpretation
  • 5.2.3 OPPORTUNITIES
    • 5.2.3.1 Expansion into emerging markets
    • 5.2.3.2 Multi modality and advanced visualization
    • 5.2.3.3 Partnerships with AI and analytics providers
    • 5.2.3.4 Value-based care and population health management
    • 5.2.3.5 Cloud native and edge computing innovations
  • 5.2.4 CHALLENGES
    • 5.2.4.1 Interoperability with legacy and vendor-specific systems
    • 5.2.4.2 High upfront integration and deployment costs
    • 5.2.4.3 Workflow disruption and user adoption
• 5.3 TRENDS/DISRUPTIONS IMPACTING CUSTOMERS' BUSINESSES
• 5.4 INDUSTRY TRENDS
  • 5.4.1 AI-ENABLED DIAGNOSTICS AND PREDICTIVE ANALYTICS
  • 5.4.2 UNIFIED IMAGING DATA INTEGRATION AND COLLABORATIVE DIAGNOSTICS
  • 5.4.3 CLOUD-BASED IMAGING IT PLATFORMS AND DIGITAL TRANSFORMATION
• 5.5 ECOSYSTEM ANALYSIS
• 5.6 SUPPLY CHAIN ANALYSIS
• 5.7 TECHNOLOGY ANALYSIS
  • 5.7.1 KEY TECHNOLOGIES
    • 5.7.1.1 Imaging analytics platforms
    • 5.7.1.2 Artificial intelligence and machine learning
    • 5.7.1.3 Multi modality fusion & co registration engines
    • 5.7.1.4 Zero footprint viewers
    • 5.7.1.5 Mobile enterprise imaging and workflow bots
  • 5.7.2 COMPLEMENTARY TECHNOLOGIES
    • 5.7.2.1 Radiology information systems (RIS)
    • 5.7.2.2 Electronic health record (EHR/EMR) integration
  • 5.7.3 ADJACENT TECHNOLOGIES
    • 5.7.3.1 Cloud computing & storage
    • 5.7.3.2 Blockchain & distributed ledger technology
• 5.8 REGULATORY ANALYSIS
  • 5.8.1 REGULATORY BODIES, GOVERNMENT AGENCIES, & OTHER ORGANIZATIONS
  • 5.8.2 REGULATORY LANDSCAPE
    • 5.8.2.1 North America
    • 5.8.2.2 Europe
    • 5.8.2.3 Asia Pacific
    • 5.8.2.4 Latin America
    • 5.8.2.5 Middle East & Africa
• 5.9 PRICING ANALYSIS
  • 5.9.1 INDICATIVE PRICING FOR ENTERPRISE IT IMAGING SOLUTIONS, BY FUNCTION (2024)
  • 5.9.2 INDICATIVE PRICING FOR ENTERPRISE IT IMAGING SOLUTIONS, BY REGION (2024)
• 5.10 PORTER'S FIVE FORCES ANALYSIS
  • 5.10.1 BARGAINING POWER OF SUPPLIERS
  • 5.10.2 BARGAINING POWER OF BUYERS
  • 5.10.3 THREAT OF SUBSTITUTES
  • 5.10.4 THREAT OF NEW ENTRANTS
  • 5.10.5 INTENSITY OF COMPETITIVE RIVALRY
• 5.11 PATENT ANALYSIS
  • 5.11.1 PATENT PUBLICATION TRENDS FOR ENTERPRISE IMAGING IT MARKET
  • 5.11.2 INSIGHTS: JURISDICTION AND TOP APPLICANT ANALYSIS
• 5.12 KEY STAKEHOLDERS & BUYING CRITERIA
  • 5.12.1 KEY STAKEHOLDERS IN BUYING PROCESS
  • 5.12.2 BUYING CRITERIA
• 5.13 END-USER ANALYSIS
  • 5.13.1 UNMET NEEDS
  • 5.13.2 END-USER EXPECTATIONS
• 5.14 KEY CONFERENCES & EVENTS, 2025-2026
• 5.15 CASE STUDY ANALYSIS
• 5.16 INVESTMENT & FUNDING SCENARIO
• 5.17 BUSINESS MODEL ANALYSIS
• 5.18 IMPACT OF GENERATIVE AI ON ENTERPRISE IMAGING IT MARKET
  • 5.18.1 TOP USE CASES & MARKET POTENTIAL
    • 5.18.1.1 Key use cases
  • 5.18.2 CASE STUDIES OF AI/GENERATIVE AI IMPLEMENTATION
    • 5.18.2.1 Case Study 1: Enabling interoperability and scalability across enterprise imaging networks with Dicom Systems' Unifier Platform
    • 5.18.2.2 Case Study 2: More images, more insight, more collaboration - San Gerardo Hospital transforms radiology with Agfa HealthCare's Enterprise Imaging
  • 5.18.3 INTERCONNECTED & ADJACENT MARKETS
    • 5.18.3.1 Vendor Neutral Archive (VNA) & PACS Market
    • 5.18.3.2 Medical Image Analysis Software Market
    • 5.18.3.3 Healthcare IT Market
  • 5.18.4 USER READINESS & IMPACT ASSESSMENT
    • 5.18.4.1 User readiness
      • 5.18.4.1.1 User A: Hospitals
      • 5.18.4.1.2 User B: Diagnostic centers
    • 5.18.4.2 Impact assessment
      • 5.18.4.2.1 User A: Hospitals
        • 5.18.4.2.1.1 Implementation
        • 5.18.4.2.1.2 Impact
      • 5.18.4.2.2 User B: Diagnostic centers
        • 5.18.4.2.2.1 Implementation
        • 5.18.4.2.2.2 Impact
• 5.19 IMPACT OF 2025 US TARIFFS ON ENTERPRISE IMAGING IT MARKET
  • 5.19.1 INTRODUCTION
  • 5.19.2 KEY TARIFF RATES
  • 5.19.3 PRICE IMPACT ANALYSIS
    • 5.19.3.1 Increased costs of hardware components
    • 5.19.3.2 Software & licensing inflation
    • 5.19.3.3 Supply chain disruption
  • 5.19.4 IMPACT ON COUNTRY/REGION
    • 5.19.4.1 US
    • 5.19.4.2 Europe
    • 5.19.4.3 Asia Pacific
  • 5.19.5 IMPACT ON END USERS
    • 5.19.5.1 Hospitals (large, mid-sized, and academic medical centers)
    • 5.19.5.2 Diagnostic centers (independent and chain-based)
    • 5.19.5.3 Teleradiology providers

6 ENTERPRISE IMAGING IT MARKET, BY FUNCTION

• 6.1 INTRODUCTION
• 6.2 VENDOR NEUTRAL ARCHIVES (VNA)
  • 6.2.1 ADVANCING SEAMLESS INFORMATION EXCHANGE THROUGH VNA SOLUTIONS TO BOOST MARKET GROWTH
• 6.3 PICTURE ARCHIVING AND COMMUNICATION SYSTEMS (PACS)
  • 6.3.1 GROWING INTEGRATION OF AI WITHIN PACS FOR OPTIMIZED RADOIOLOGY WORKFLOWS TO SUPPORT MARKET GROWTH
• 6.4 IMAGE EXCHANGE
  • 6.4.1 GROWING POPULARITY OF INTEROPERABLE IMAGING NETWORKS FOR PATIENT-CENTERED DATA SHARING TO DRIVE GROWTH
• 6.5 UNIVERSAL VIEWERS
  • 6.5.1 GROWING UNIVERSAL VIEWER DEPLOYMENT FOR MULTI-DISCIPLINARY IMAGING TO FUEL MARKET
• 6.6 WORKFLOW ORCHESTRATION
  • 6.6.1 AI-POWERED IMAGING WORKFLOW AUTOMATION AND CROSS-MODALITY COORDINATION TO PROPEL MARKET
• 6.7 ANALYTICS
  • 6.7.1 GROWING NEED FOR ANALYTICS PLATFORMS FOR VALUE-BASED IMAGING AND OPERATIONAL OPTIMIZATION TO DRIVE MARKET
• 6.8 OTHER FUNCTIONS

7 ENTERPRISE IMAGING IT MARKET, BY APPLICATION

• 7.1 INTRODUCTION
• 7.2 DIAGNOSTICS
  • 7.2.1 AI-ENABLED QUANTIFICATION AND INTEGRATED THERANOSTIC WORKFLOWS TO DRIVE DIAGNOSTIC IMAGING TRANSFORMATION
• 7.3 THERAPEUTICS
  • 7.3.1 ADVANTAGES SUCH AS MULTIMODAL TREATMENT INTEGRATION TO OPTIMIZE ENTERPRISE IMAGING FOR THERAPEUTIC WORKFLOWS
• 7.4 CLINICAL RESEARCH
  • 7.4.1 AI-ENABLED QUANTIFICATION AND RAPID-RESPONSE IMAGING WORKFLOWS TO ACCELERATE CLINICAL RESEARCH

8 ENTERPRISE IMAGING IT MARKET, BY MODALITY

• 8.1 INTRODUCTION
• 8.2 X-RAY
  • 8.2.1 GROWTH IN ENTERPRISE IMAGING THROUGH AI-ENABLED X-RAY SOLUTIONS TO BOOST MARKET
• 8.3 MAGNETIC RESONANCE IMAGING (MRI)
  • 8.3.1 EXPANDING MRI ENTERPRISE IT TO MEET RISING NEUROLOGICAL IMAGING DEMANDS TO SUPPORT MARKET GROWTH
• 8.4 COMPUTED TOMOGRAPHY (CT)
  • 8.4.1 REGULATORY AND VALUE-BASED INCENTIVES TO FUEL CT IMAGING IT ADOPTION
• 8.5 ULTRASOUND
  • 8.5.1 AI-POWERED ULTRASOUND AND POCUS TO ACCELERATE ENTERPRISE IMAGING TRANSFORMATION
• 8.6 NUCLEAR IMAGING
  • 8.6.1 POSITRON EMISSION TOMOGRAPHY (PET)
    • 8.6.1.1 Rising PET scan volumes to drive demand for scalable, intelligent Imaging IT
  • 8.6.2 SINGLE-PHOTON EMISSION COMPUTED TOMOGRAPHY (SPECT)
    • 8.6.2.1 Driving diagnostic accuracy with automated SPECT workflows to contribute to growth
• 8.7 ENDOSCOPY
  • 8.7.1 ENABLING REAL-TIME ENDOSCOPIC INSIGHTS THROUGH CLOUD-NATIVE VIDEO ORCHESTRATION TO DRIVE MARKET
• 8.8 MAMMOGRAPHY
  • 8.8.1 NEED FOR ENTERPRISE IMAGING SOLUTIONS FOR HIGH-VOLUME, HIGH-RESOLUTION MAMMOGRAPHY WORKFLOWS TO FUEL GROWTH
• 8.9 FLUOROSCOPY
  • 8.9.1 STRATEGIC CLOUD-NATIVE IMAGING FOR ADVANCED FLUOROSCOPY USE CASES TO AID WITH GROWTH
• 8.10 ECHOCARDIOGRAPHY
  • 8.10.1 ABILITY TO ENHANCE FLUOROSCOPY IMAGING EFFICIENCY WITH AI-INTEGRATED ENTERPRISE IT SOLUTIONS TO BOOST MARKET
• 8.11 OTHER MODALITIES

9 ENTERPRISE IMAGING IT MARKET, BY OFFERING

• 9.1 INTRODUCTION
• 9.2 SOFTWARE
  • 9.2.1 ADVANCING UNIFIED IMAGING ECOSYSTEMS THROUGH CLOUD-NATIVE SOFTWARE TO BOOST MARKET GROWTH
• 9.3 SERVICES
  • 9.3.1 ADVANTAGES SUCH AS EXPERT SERVICES, CLOUD MIGRATION, AND WORKFLOW OPTIMIZATION TO SUPPORT MARKET GROWTH

10 ENTERPRISE IMAGING IT MARKET, BY DEPLOYMENT MODE

• 10.1 INTRODUCTION
• 10.2 ON-PREMISE SOLUTIONS
  • 10.2.1 GROWING NEED FOR IMAGING PERFORMANCE AND DATA CONTROL THROUGH ON-PREMISE DEPLOYMENT TO SUPPORT MARKET GROWTH
• 10.3 CLOUD-BASED SOLUTIONS
  • 10.3.1 RISING NEED FOR COST-EFFICIENT, SCALABLE INFRASTRUCTURE TO DRIVE DEMAND FOR CLOUD-BASED DEPLOYMENT
• 10.4 HYBRID SOLUTIONS
  • 10.4.1 ABILITY TO BRIDGE DATA CONTROL AND CLOUD INNOVATION THROUGH HYBRID DEPLOYMENT TO BOOST GROWTH

11 ENTERPRISE IMAGING IT MARKET, BY THERAPEUTIC AREA

• 11.1 INTRODUCTION
• 11.2 NEUROLOGY
  • 11.2.1 INTEGRATION OF AI-DRIVEN MULTIMODAL NEUROIMAGING FOR PERSONALIZED NEUROLOGICAL CARE TO BOOST MARKET
• 11.3 CARDIOLOGY
  • 11.3.1 CLOUD-ENABLED, AI-DRIVEN ENTERPRISE IMAGING PLATFORMS TO ACCELERATE ADVANCED CARDIAC DIAGNOSTICS
• 11.4 ONCOLOGY
  • 11.4.1 AI-DRIVEN, MULTIMODAL ENTERPRISE IMAGING PLATFORMS TO ADVANCE PRECISION ONCOLOGY
• 11.5 ORTHOPEDICS
  • 11.5.1 ABILITY OF AI-ENABLED ENTERPRISE IMAGING PLATFORMS TO TRANSFORM ORTHOPEDIC CARE TO DRIVE DEMAND
• 11.6 OTHER THERAPEUTIC AREAS

12 ENTERPRISE IMAGING IT MARKET, BY END USER

• 12.1 INTRODUCTION
• 12.2 HOSPITALS
  • 12.2.1 HOSPITALS TO DRIVE DEMAND FOR UNIFIED IMAGING INFRASTRUCTURE TO SUPPORT INTEGRATED CARE DELIVERY
• 12.3 DIAGNOSTIC CENTERS
  • 12.3.1 GROWING ADOPTION OF ENTERPRISE IMAGING IT TO ENHANCE WORKFLOW EFFICIENCY IN DIAGNOSTIC CENTERS TO BOOST MARKET
• 12.4 CLINICS & OUTPATIENT SETTINGS
  • 12.4.1 GROWING POPULARITY OF LIGHTWEIGHT ENTERPRISE IMAGING IT TO BOOST EFFICIENCY AND PATIENT THROUGHPUT TO FUEL GROWTH
• 12.5 PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES
  • 12.5.1 GROWING USE OF ENTERPRISE IMAGING IT FOR TRANSLATIONAL RESEARCH AND DRUG DEVELOPMENT TO DRIVE MARKET
• 12.6 MEDTECH COMPANIES
  • 12.6.1 ABILITY OF ENTERPRISE IMAGING IT TO ACCELERATE DEVICE INNOVATION AND CLINICAL INTEGRATION TO FUEL ADOPTION
• 12.7 RESEARCH & ACADEMIC INSTITUTES
  • 12.7.1 GROWING NEED TO POWER DATA-DRIVEN DISCOVERY AND COLLABORATION TO SUPPORT MARKET GROWTH
• 12.8 OTHER END USERS

13 ENTERPRISE IMAGING IT MARKET, BY REGION

• 13.1 INTRODUCTION
• 13.2 NORTH AMERICA
  • 13.2.1 MACROECONOMIC OUTLOOK FOR NORTH AMERICA
  • 13.2.2 US
    • 13.2.2.1 AI integration, cloud adoption, and regulatory push to accelerate enterprise imaging IT transformation in US
  • 13.2.3 CANADA
    • 13.2.3.1 Provincial interoperability mandates and cloud-enabled AI to drive growth in Canada's imaging IT market
• 13.3 EUROPE
  • 13.3.1 MACROECONOMIC OUTLOOK FOR EUROPE
  • 13.3.2 GERMANY
    • 13.3.2.1 Hospital modernization and ePA adoption to propel Germany's enterprise imaging IT growth
  • 13.3.3 UK
    • 13.3.3.1 NHS push for AI-driven imaging and cloud integration to fuel market growth
  • 13.3.4 FRANCE
    • 13.3.4.1 France to accelerate cloud-native, interoperable imaging platforms with focus on data sovereignty
  • 13.3.5 ITALY
    • 13.3.5.1 Growing VNA and teleradiology adoption in Italy to modernize imaging infrastructure
  • 13.3.6 SPAIN
    • 13.3.6.1 Spain to scale cloud imaging and VNA for regional collaboration
  • 13.3.7 REST OF EUROPE
• 13.4 ASIA PACIFIC
  • 13.4.1 MACROECONOMIC OUTLOOK FOR ASIA PACIFIC
  • 13.4.2 CHINA
    • 13.4.2.1 AI diagnostic approvals to accelerate market growth
  • 13.4.3 JAPAN
    • 13.4.3.1 Aging demographics to drive demand for scalable imaging solutions
  • 13.4.4 INDIA
    • 13.4.4.1 Government-led digitization to fuel imaging infrastructure expansion
  • 13.4.5 REST OF ASIA PACIFIC
• 13.5 LATIN AMERICA
  • 13.5.1 MACROECONOMIC OUTLOOK FOR LATIN AMERICA
  • 13.5.2 BRAZIL
    • 13.5.2.1 Government investments to accelerate public health digitization drives
  • 13.5.3 MEXICO
    • 13.5.3.1 Accelerating imaging modernization through nationwide digital integration in Mexico to boost market
  • 13.5.4 REST OF LATIN AMERICA
• 13.6 MIDDLE EAST & AFRICA
  • 13.6.1 MACROECONOMIC OUTLOOK FOR MIDDLE EAST & AFRICA
  • 13.6.2 GCC COUNTRIES
    • 13.6.2.1 Enterprise imaging adoption accelerates across GCC amid workforce gaps and digital health push to support growth
  • 13.6.3 REST OF MIDDLE EAST & AFRICA

14 COMPETITIVE LANDSCAPE

• 14.1 OVERVIEW
• 14.2 KEY PLAYER STRATEGIES/RIGHT TO WIN
  • 14.2.1 OVERVIEW OF STRATEGIES ADOPTED BY KEY PLAYERS IN ENTERPRISE IMAGING IT MARKET
• 14.3 REVENUE ANALYSIS, 2020-2024
• 14.4 MARKET SHARE ANALYSIS, 2024
• 14.5 COMPANY EVALUATION MATRIX: KEY PLAYERS, 2024
  • 14.5.1 STARS
  • 14.5.2 EMERGING LEADERS
  • 14.5.3 PERVASIVE PLAYERS
  • 14.5.4 PARTICIPANTS
  • 14.5.5 COMPANY FOOTPRINT: KEY PLAYERS, 2024
    • 14.5.5.1 Company footprint
    • 14.5.5.2 Region footprint
    • 14.5.5.3 Function footprint
    • 14.5.5.4 Application footprint
    • 14.5.5.5 Therapeutic area footprint
    • 14.5.5.6 Deployment mode footprint
• 14.6 COMPANY EVALUATION MATRIX: STARTUPS/SMES, 2024
  • 14.6.1 PROGRESSIVE COMPANIES
  • 14.6.2 RESPONSIVE COMPANIES
  • 14.6.3 DYNAMIC COMPANIES
  • 14.6.4 STARTING BLOCKS
  • 14.6.5 COMPETITIVE BENCHMARKING: STARTUPS/SMES, 2024
    • 14.6.5.1 Detailed list of key startups/SMEs
    • 14.6.5.2 Competitive benchmarking of startups/SMEs
• 14.7 COMPANY VALUATION & FINANCIAL METRICS
  • 14.7.1 FINANCIAL METRICS
  • 14.7.2 COMPANY VALUATION
• 14.8 BRAND/SOFTWARE COMPARISON
• 14.9 COMPETITIVE SCENARIO
  • 14.9.1 SOLUTION LAUNCHES, APPROVALS, AND ENHANCEMENTS
  • 14.9.2 DEALS
  • 14.9.3 EXPANSIONS

15 COMPANY PROFILES

• 15.1 KEY PLAYERS
  • 15.1.1 AGFA-GEVAERT GROUP
    • 15.1.1.1 Business overview
    • 15.1.1.2 Solutions offered
    • 15.1.1.3 Recent developments
      • 15.1.1.3.1 Deals
    • 15.1.1.4 MnM view
      • 15.1.1.4.1 Key strengths
      • 15.1.1.4.2 Strategic choices
      • 15.1.1.4.3 Weaknesses & competitive threats
  • 15.1.2 FUJIFILM HOLDINGS CORPORATION
    • 15.1.2.1 Business overview
    • 15.1.2.2 Solutions offered
    • 15.1.2.3 Recent developments
      • 15.1.2.3.1 Deals
    • 15.1.2.4 MnM view
      • 15.1.2.4.1 Key strengths
      • 15.1.2.4.2 Strategic choices
      • 15.1.2.4.3 Weaknesses & competitive threats
  • 15.1.3 GE HEALTHCARE
    • 15.1.3.1 Business overview
    • 15.1.3.2 Solutions offered
    • 15.1.3.3 Recent developments
      • 15.1.3.3.1 Solution launches & approvals
      • 15.1.3.3.2 Deals
    • 15.1.3.4 MnM view
      • 15.1.3.4.1 Key strengths
      • 15.1.3.4.2 Strategic choices
      • 15.1.3.4.3 Weaknesses & competitive threats
  • 15.1.4 KONINKLIJKE PHILIPS N.V.
    • 15.1.4.1 Business overview
    • 15.1.4.2 Solutions offered
    • 15.1.4.3 Recent developments
      • 15.1.4.3.1 Solution launches & approvals
      • 15.1.4.3.2 Deals
      • 15.1.4.3.3 Expansions
    • 15.1.4.4 MnM view
      • 15.1.4.4.1 Key strengths
      • 15.1.4.4.2 Strategic choices
      • 15.1.4.4.3 Weaknesses & competitive threats
  • 15.1.5 SIEMENS HEALTHINEERS AG
    • 15.1.5.1 Business overview
    • 15.1.5.2 Solutions offered
    • 15.1.5.3 Recent developments
      • 15.1.5.3.1 Solution launches
      • 15.1.5.3.2 Deals
    • 15.1.5.4 MnM view
      • 15.1.5.4.1 Key strengths
      • 15.1.5.4.2 Strategic choices
      • 15.1.5.4.3 Weaknesses & competitive threats
  • 15.1.6 OPTUM, INC.
    • 15.1.6.1 Business overview
    • 15.1.6.2 Solutions offered
    • 15.1.6.3 Recent developments
      • 15.1.6.3.1 Deals
    • 15.1.6.4 MnM view
      • 15.1.6.4.1 Key strengths
      • 15.1.6.4.2 Strategic choices
      • 15.1.6.4.3 Weaknesses & competitive threats
  • 15.1.7 SECTRA AB
    • 15.1.7.1 Business overview
    • 15.1.7.2 Solutions offered
    • 15.1.7.3 Recent developments
      • 15.1.7.3.1 Solution launches & approvals
      • 15.1.7.3.2 Deals
  • 15.1.8 CANON MEDICAL SYSTEMS CORPORATION
    • 15.1.8.1 Business overview
    • 15.1.8.2 Solutions offered
    • 15.1.8.3 Recent developments
      • 15.1.8.3.1 Deals
      • 15.1.8.3.2 Expansions
  • 15.1.9 MERATIVE
    • 15.1.9.1 Business overview
    • 15.1.9.2 Solutions offered
    • 15.1.9.3 Recent developments
      • 15.1.9.3.1 Deals
      • 15.1.9.3.2 Expansions
  • 15.1.10 PRO MEDICUS, LTD.
    • 15.1.10.1 Business overview
    • 15.1.10.2 Solutions offered
    • 15.1.10.3 Recent developments
      • 15.1.10.3.1 Solution launches
      • 15.1.10.3.2 Deals
  • 15.1.11 INTELERAD MEDICAL SYSTEMS INCORPORATED
    • 15.1.11.1 Business overview
    • 15.1.11.2 Solutions offered
    • 15.1.11.3 Recent developments
      • 15.1.11.3.1 Solution launches
      • 15.1.11.3.2 Deals
  • 15.1.12 HYLAND SOFTWARE, INC.
    • 15.1.12.1 Business overview
    • 15.1.12.2 Solutions offered
    • 15.1.12.3 Recent developments
      • 15.1.12.3.1 Solution launches
      • 15.1.12.3.2 Deals
  • 15.1.13 INFINITT HEALTHCARE CO., LTD.
    • 15.1.13.1 Business overview
    • 15.1.13.2 Solutions offered
    • 15.1.13.3 Recent developments
      • 15.1.13.3.1 Solution launches & approvals
      • 15.1.13.3.2 Deals
  • 15.1.14 NOVARAD
    • 15.1.14.1 Business overview
    • 15.1.14.2 Solutions offered
  • 15.1.15 MACH7 TECHNOLOGIES
    • 15.1.15.1 Business overview
    • 15.1.15.2 Solutions offered
    • 15.1.15.3 Recent developments
      • 15.1.15.3.1 Solution launches
      • 15.1.15.3.2 Deals
  • 15.1.16 HERMES MEDICAL SOLUTIONS
    • 15.1.16.1 Business overview
    • 15.1.16.2 Solutions offered
    • 15.1.16.3 Recent developments
      • 15.1.16.3.1 Solution launches, approvals, and enhancements
      • 15.1.16.3.2 Deals
  • 15.1.17 KONICA MINOLTA, INC.
    • 15.1.17.1 Business overview
    • 15.1.17.2 Solutions offered
    • 15.1.17.3 Recent developments
      • 15.1.17.3.1 Solution launches & enhancements
      • 15.1.17.3.2 Deals
  • 15.1.18 BRIDGEHEAD SOFTWARE LTD.
    • 15.1.18.1 Business overview
    • 15.1.18.2 Solutions offered
    • 15.1.18.3 Recent developments
      • 15.1.18.3.1 Deals
  • 15.1.19 SCIMAGE, INC.
    • 15.1.19.1 Business overview
    • 15.1.19.2 Solutions offered
    • 15.1.19.3 Recent developments
      • 15.1.19.3.1 Solution launches
      • 15.1.19.3.2 Deals
  • 15.1.20 VISUS HEALTH IT GMBH
    • 15.1.20.1 Business overview
    • 15.1.20.2 Solutions offered
    • 15.1.20.3 Recent developments
      • 15.1.20.3.1 Solution enhancements
• 15.2 OTHER PLAYERS
  • 15.2.1 DICOM SYSTEMS, INC.
  • 15.2.2 POSTDICOM
  • 15.2.3 QAELUM
  • 15.2.4 ADVAHEALTH SOLUTIONS
  • 15.2.5 PAXERAHEALTH
  • 15.2.6 RAD AI

16 APPENDIX

• 16.1 DISCUSSION GUIDE
• 16.2 KNOWLEDGESTORE: MARKETSANDMARKETS' SUBSCRIPTION PORTAL
• 16.3 CUSTOMIZATION OPTIONS
• 16.4 RELATED REPORTS
• 16.5 AUTHOR DETAILS